Sunday, September 30, 2018

Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to new data.

from Top Health News -- ScienceDaily https://ift.tt/2QmSzBG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ozempic may have revealed the brain’s hidden “craving center”

Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists ar...